Abstract:Hypoxia is the major influence factor in physiological and pathological courses which are mainly mediated by hypoxia-inducible factors (HIFs) in response to low oxygen tensions within solid tumors. Under normoxia, HIF signaling pathway is inhibited due to HIF-α subunits degradation. However, in hypoxic conditions, HIF-α is activated and stabilized, and HIF target genes are successively activated, resulting in a series of tumour-specific activities. The activation of HIFs, including HIF-1α, HIF-2α and HIF-3α, subsequently induce downstream target genes which leads to series of responses, the resulting abnormal processes or metabolites in turn affect HIFs stability. Given its functions in tumors progression, HIFs have been regarded as therapeutic targets for improved treatment efficacy. Epigenetics refers to alterations in gene expression that are stable between cell divisions, and sometimes between generations, but do not involve changes in the underlying DNA sequence of the organism. And with the development of research, epigenetic regulation has been found to play an important role in the development of tumors, which providing accumulating basic or clinical evidences for tumor treatments. Here, given how little has been reported about the overall association between hypoxic tumors and epigenetics, we made a more systematic review from epigenetic perspective in hope of helping others better understand hypoxia or HIF pathway, and providing more established and potential therapeutic strategies in tumors to facilitate epigenetic studies of tumors.

Romance of the three kingdoms in hypoxia: HIFs, epigenetic regulators, and chromatin reprogramming

Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation

Transcriptional Response to Hypoxia: The Role of HIF-1-Associated Co-Regulators

Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications

Role of histone methylation in hypoxic response of tumor

Role of hypoxia in the hallmarks of human cancer.

The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions

Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression

Role of hypoxia in cancer therapy by regulating the tumor microenvironment

Hypoxia-regulated gene network in drug resistance and cancer progression

Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies

Cancer Therapy by Targeting Hypoxia-Inducible Factor-1.

Epigenetic coordination of transcriptional and translational programs in hypoxia

Interplay of long non-coding RNAs and HIF-1α: A new dimension to understanding hypoxia-regulated tumor growth and metastasis

Small Molecules Targeting HIF-1α Pathway for Cancer Therapy in Recent Years

HIF-1: structure, biology and natural modulators

Central role of hypoxia-inducible factor-1α in metabolic reprogramming of cancer cells: A review

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?

Tumor hypoxia: From basic knowledge to therapeutic implications

The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance